Part of the Biomarker101 webinar series, Pathology 101 addresses the role of laboratory medicine professionals and pathologists in biomarker testing, incorporating a review of testing techniques and applications, lab-specific regulations, and the impact of those regulations on biomarker testing.
Annette S. Kim, MD, PhD, Associate Professor of Pathology, Harvard Medical School; Hematopathologist And Molecular Pathologist, Brigham And Women's Hospital, Boston, MA
Michelle Shiller, DO, AP/CP, MGP, Co-Medical Director of Genetics, Baylor Sammons Cancer Center; Staff Pathologist, Baylor University Medical Center, Dallas, TX
This webinar is part of the BiomarkerLIVE education project and is supported by AbbVie, AstraZeneca, Lilly Oncology, and Merck & Co., Inc.
You must have an ACCC or state society account to register for this webinar.
If You DO NOT Have an Account:
- To start, click the green “Register” button in the upper right corner of this page. You will be directed to “Your Cart.” Click the green “Log In” button near the top of the page.
- ACCC and State Society Members: Click “Reset Password” to update your login information. When your password is updated, you will be redirected to the “My Profile” page.
- Non-members: Click “Create Account.” Once your password is created, you will be redirected to the "My Profile" page.
- Click “eLearning” at the top of your profile page to go back to the ACCC eLearning portal. In the box on the left side of the screen, click on the “Cart” link.
- The green box in the upper right corner of this page will indicate “You are registered!” for this course!
If You Have an Account:
- Please click the orange “Log In” button on the left side of this screen. You will be taken to the main login page that displays your email and password. Click the “Log in” button.
- You will be automatically redirected back to webinar page, and the green box in the upper right corner will say that “You are registered!” for this course!
PRO TIP: If you save your ACCC password to your computer and remain logged in, you can register for additional webinars and courses in a matter of seconds—with just one click!
For the best registration and viewing experience, please use Chrome, Edge, or Safari web browsers. Internet Explorer Users may experience difficulties accessing the webinar.
Once you complete your registration, you will receive an email from ACCC eLearning, which contains information on how to access this webinar. For assistance with registration or if you do not receive an email, please contact email@example.com.
Annette S. Kim, MD, PhD
Associate Professor of Pathology, Harvard Medical School; Hematopathologist and Molecular Pathologist, Brigham and Women's Hospital
Dr. Annette S. Kim, MD, PhD, is an Associate Professor of Pathology at Harvard Medical School and a practicing hematopathologist and molecular pathologist at Brigham and Women's Hospital. She has prior training in synthetic organic chemistry as well as structural biology and spent several years in the pharmaceutical industry prior to her return to academia. Since returning to clinical practice, she has practices diagnostic hematopathology and molecular pathology, and is the Associate Director of the Center for Advanced Molecular Diagnostics in which role she has directed assay validation and quality assurance. Her research program has focused on the study of myeloid neoplasms, mutational patterns in hematopoietic neoplasms, and test utilization. Her research program has identified diagnostic and prognostic small non-coding RNAs in MDS via next generation sequencing and has defined the role of hypermethylation in the regulation of miRNAs in MDS. She has studied the effects of potential therapeutic compounds on cellular function in miRNA-based models of the MDS and in primary clinical samples using single cell phenotyping by mass cytometry with correlation to the mutational profiles of these samples. In addition, she has experience implementing, receiving funding for, and publishing on efforts in test utilization management, conducting studies on cost effective practice of hematopathology. She has been an active member of the Association of Molecular Pathology, serving as Chair of several committees and a member of the Executive Committee, Strategic Opportunities Committee, and Board. She also serves on the College of American Pathologists Molecular Oncology Committee. Through these Societies she has published key papers on myeloid mutational patterns and performance of FDA companion diagnostics and laboratory developed assays, including performance of next generation sequencing assays.
Michelle Shiller, DO, AP/CP, MGP
Co-Medical Director of Genetics, Baylor Sammons Cancer Center; Staff Pathologist, Baylor University Medical Center
Dr. Michelle Shiller, DO, AP/CP, MGP, is board certified in Anatomic, Clinical, and Molecular Genetic Pathology following completion of residency at Baylor University Medical Center in Dallas, Texas and fellowship at The Mayo Clinic in Rochester, Minnesota. Upon completion of training, Dr. Shiller established practice with Pathologists Biomedical Laboratories in Dallas, Texas, who services the majority of the DFW metroplex Baylor Scott and White Hospitals. As a result of her experience, she has served on multiple committees considering testing implementation and utilization. Dr. Shiller serves on the Quality Committee for the Baylor Sammons Cancer Center, and as Assistant Medical Director for Cancer Genetics, primarily focusing on germline cancer predisposition, as well as Co-Assistant Medical Director for the Division of Molecular Medicine and Pathology. Finally, within the Baylor Scott and White system, Dr. Shiller has also served on the Baylor Medical Board.
As a result of the emerging field of molecular pathology, Dr. Shiller has provided many educational forums to empower providers and break down barriers to implementation. This has led to Dr. Shiller securing the opportunity and embracing her passion for educating individuals at a larger scale, through the support and encouragement of many pharmaceutical companies in the form of speaking programs, video recordings, webinars and content development. Consequently, Dr. Shiller has also served on steering committees and advisory boards for multiple entities. Dr. Shiller is an active member of the Association for Molecular Pathology, and also served to develop a consistent dialogue between molecular pathology and oncology, assisting with developing the ASCO-sponsored Molecular Tumor Board. With a patient-centered focus, quality, accuracy, relevance, timeliness, teamwork and conscientious stewardship of the patient specimen are considerations that Dr. Shiller is inspired to bring to reality with the ongoing integration of molecular diagnostics in the field of oncology. She is excited to partner with the Association of Community Cancer Centers on the Board of Trustees to further impact patient care positively with this focus.
Additional ACCC Resources to Supplement Your Learning
- ACCC members can connect in real-time through members-only virtual discussion forum on ACCCeXchange. Within this forum, ACCC members from every profession involved in cancer care delivery ask and answer questions, discuss common challenges, and share knowledge and experience. Join the discussion and connect with your peers.
- Looking to become a member of the Association of Community Cancer Centers? Visit our membership page for more information on the types of membership we offer and how you can become involved. If you’re unsure whether or not you’re already a member, please contact our membership department today.
- The ACCCeLearning portal makes it easy to find education relevant to your needs and interests. Accessible on any device and at any time, courses are available in a variety of formats, so you can listen, watch, read or interact in ways that best suit your needs. Health professionals can claim CME/CPE/CNE credit for all applicable activities. Since you’re already logged in, take a look around today!